Related Experiment Videos
Genetic engineering of factor VIII
1Cellular Genetics, Genetics Institute, Cambridge, Massachusetts 02140.
Nature
|November 9, 1989
Summary
Genetic engineering of mammalian cells enables the production of large amounts of pure, virus-free factor VIII. This represents a significant advancement in recombinant DNA technology for complex protein manufacturing.
Area of Science:
- Biotechnology
- Molecular Biology
- Protein Engineering
Background:
- Factor VIII is crucial for blood coagulation.
- Previous methods for obtaining Factor VIII were limited in purity and quantity.
- The complexity of Factor VIII has made its production challenging.
Purpose of the Study:
- To develop a method for large-scale, high-purity production of Factor VIII.
- To utilize recombinant DNA (rDNA) technology for manufacturing complex proteins.
- To overcome limitations of traditional Factor VIII sourcing.
Main Methods:
- Genetic manipulation of mammalian cell lines.
- Application of recombinant DNA technology.
- Purification techniques for protein isolation.
Main Results:
- Achieved unlimited quantities of Factor VIII.
- Produced a high-purity preparation.
- Ensured the preparation was virus-free.
- Demonstrated successful manufacturing of a highly complex protein via rDNA technology.
Conclusions:
- Mammalian cell genetic engineering is effective for producing therapeutic proteins like Factor VIII.
- rDNA technology has advanced the capability to manufacture complex biological molecules.
- This method offers a reliable and safe source of Factor VIII.